ABSTRACT
The well-characterized suppression of the male reproductive unit after ethanol (EtOH) exposure has been speculated to be partially due to activation of the hypothalamic-pituitary-adrenal (HPA) axis. The subsequent corticosterone elevation could result in hypogonadism via suppression of hypothalamic LHRH, pituitary LH, or a direct gonadal effect. To directly examine this possibility, adult male Sprague Dawley rats were either adrenalectomized (ADX) or sham ADX. The ADX animals were given low dose corticosterone via replacement pellet, resulting in a steady level of serum corticosterone. The sham ADX (adrenal intact) animals were implanted with placebo pellets. Half of both groups were then exposed to EtOH by I.P. injection on two consecutive days to mimic an acute binge-drinking model. The other half was given saline I.P., serving as controls. In the adrenal intact animals, EtOH caused the expected rise in corticosterone, and fall in luteinizing hormone (LH) and testosterone. In the ADX animals, where constant levels of corticosterone were maintained by pellet implantation, EtOH resulted in similar LH and testosterone reduction. These results suggest that suppression of the reproductive axis is independent of the activation of the HPA unit.
Subject(s)
Adrenal Glands/drug effects , Ethanol/toxicity , Hypogonadism/chemically induced , Hypothalamus/drug effects , Pituitary Gland/drug effects , Adrenal Glands/physiopathology , Adrenalectomy , Animals , Corticosterone/administration & dosage , Corticosterone/blood , Ethanol/blood , Gonadotropin-Releasing Hormone/metabolism , Hypogonadism/physiopathology , Hypothalamus/physiopathology , Luteinizing Hormone/blood , Male , Pituitary Gland/physiopathology , Rats , Rats, Sprague-Dawley , Testosterone/bloodABSTRACT
Angiogenesis that is induced by cancers, including those of the head and neck, requires endothelial cells to shift from a nonmotile resting state to an increased level of motility. Using a human microvascular endothelial cell line, this study shows the importance of the serine/threonine protein phosphatases 1 (PP1) and 2A (PP2A) in restricting endothelial cell motility. Treatment of endothelial cells with increasing concentrations of the PP1 and PP2A inhibitor okadaic acid resulted in cell rounding and increased motility, which was accompanied by cytoskeletal disorganization involving a loss of filamentous beta-tubulin and F-actin. These effects occurred at okadaic acid levels that selectively inhibit PP2A and became more prominent with higher levels that inhibit both PP2A and PP1. This study shows the importance of PP1 and PP2A in maintaining cytoskeletal organization, thereby limiting endothelial cell motility, and suggests that pharmacologic approaches to enhance PP1 and PP2A activities may be useful in preventing key events of the angiogenic process.
Subject(s)
Cell Movement/physiology , Endothelium, Vascular/physiopathology , Neovascularization, Pathologic/physiopathology , Otorhinolaryngologic Neoplasms/blood supply , Phosphoprotein Phosphatases/physiology , Cell Division/physiology , Cell Line , Cytoskeleton/physiology , HumansABSTRACT
Advances in head and neck surgical techniques with aggressive adjuvant treatment have reduced the incidence of locoregional failure in many types of head and neck cancer. Failure to control distant disease, however, remains of the most frustrating aspects in the care of these patients. A strong foundation in the biology of invasion and metastasis is necessary to understand more clearly the reasons for the development of distant and locally recurrent disease. This article focuses on basic mechanisms of invasion and metastasis in head and neck squamous cell carcinoma.
Subject(s)
Head and Neck Neoplasms/genetics , Head and Neck Neoplasms/pathology , Lymphatic Metastasis , Neoplasm Invasiveness , Neoplasms, Squamous Cell/genetics , Neoplasms, Squamous Cell/pathology , Humans , Lymphatic Metastasis/pathology , Lymphatic Metastasis/physiopathology , Neoplasms, Squamous Cell/secondary , Neovascularization, PathologicABSTRACT
Patients with head and neck squamous cell carcinoma (HNSCC) have profound immune deficiencies. In 65% of these patients, there is an increased intra-tumoral presence of immune-suppressive CD34+ progenitor cells. The goal of the present study was to determine whether CD34+ cell levels were also increased in the peripheral blood of HNSCC patients and if these immune-suppressive cells could be differentiated into dendritic cells. Our results showed that CD34+ cell levels are increased in the peripheral blood of HNSCC patients. To assess if these CD34+ cells could differentiate into dendritic cells, they were isolated from the blood of HNSCC patients and cultured for 12 days with various cytokine combinations. Culturing CD34+ cells with stem cell factor (c-kit ligand) plus granulocyte-macrophage colony-stimulating factor resulted in the appearance of a significant proportion of cells expressing phenotypic markers characteristic of dendritic cells. Also, including tumor necrosis factor-alpha yielded a significant proportion of cells resembling the bipotential precursor cells for dendritic cells and monocytes (CD14+CD1a+), in addition to the dendritic-like cells. When the differentiation inducer 1alpha,25-dihydroxyvitamin D3 [1,25(OH)2D3] was added along with the cytokine combinations, the yield of cells having characteristics of dendritic cells was further increased. Cells that were derived from CD34+ cell cultures containing 1,25(OH)2D3 had a more potent capacity to present the recall antigen tetanus toxoid to autologous peripheral blood leukocytes and to stimulate a mixed leukocyte response compared to cultures to which 1,25(OH)2D3 had not been added. Our results show that CD34+ cells, whose frequency is increased in HNSCC patients, can be differentiated into cells that phenotypically and functionally resemble dendritic cells and that 1,25(OH)2D3 accentuates this differentiation.
Subject(s)
Antigens, CD34/immunology , Carcinoma, Squamous Cell/pathology , Cell Differentiation , Dendritic Cells/pathology , Head and Neck Neoplasms/pathology , T-Lymphocytes, Regulatory/pathology , Antigen Presentation , Carcinoma, Squamous Cell/immunology , Cell Differentiation/drug effects , Cells, Cultured , Cholecalciferol/pharmacology , Flow Cytometry , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Head and Neck Neoplasms/immunology , Humans , Leukocytes, Mononuclear/immunology , Lymphocyte Count , Recombinant Proteins , Stem Cell Factor/pharmacology , T-Lymphocytes, Regulatory/immunologyABSTRACT
BACKGROUND: Tumor growth is dependent on the expansion and proliferation of the host vascular system into the primary neoplasm (angiogenesis). The development of an intact vascular system requires migration and proliferation of endothelial cells and assembly into microvessels. Previous studies in our laboratory demonstrated that head and neck squamous cell carcinomas (HNSCC) are angiogenic in vivo. To clarify the mechanism of HNSCC-induced angiogenesis, the present study sought to determine if HNSCCs produced endothelial cell mitogens in vitro. METHODS: Production of PGE-2, TGF-beta, FGF-2 (basic-FGF [fibroblast growth factor]), and vascular endothelial cell growth factor (VEGF) were quantitated by enzyme-linked immunoabsorbant assay (ELISA) in five HNSCC lines. Cell free supernatants of 5 HNSCC lines were tested in a nonradioactive proliferation assay using human umbilical vein endothelial cells (HUVECs). RESULTS: All lines demonstrated enhanced endothelial cell proliferation in a dose-dependent fashion. Fractionation of these supernatants by heparin column chromatography significantly reduced endothelial cell proliferation in the five lines tested (range, 31.7% to 46.23% reduction; mean, 38.14+/-6.02%). Pretreatment with antibody to VEGF but not transforming growth factor (TGF)-beta inhibited endothelial cell proliferation. CONCLUSIONS: These studies indicate HNSCCs produce factor(s) which stimulate endothelial cell proliferation and that VEGF may be involved in HNSCC-induced endothelial cell mitogenesis.
Subject(s)
Carcinoma, Squamous Cell/blood supply , Cytokines/biosynthesis , Endothelium/metabolism , Fibroblast Growth Factor 2/biosynthesis , Head and Neck Neoplasms/blood supply , Neovascularization, Pathologic/physiopathology , Carcinoma, Squamous Cell/physiopathology , Cell Division , Chromatography, Affinity , Dinoprostone/biosynthesis , Endothelial Growth Factors/biosynthesis , Endothelium/cytology , Head and Neck Neoplasms/physiopathology , Humans , Transforming Growth Factor beta/biosynthesis , Tumor Cells, CulturedABSTRACT
Human head and neck squamous cell carcinomas (HNSCC) that produce high levels of granulocyte-macrophage colony-stimulating factor (GM-CSF) have been shown to contain CD34+ natural suppressor cells that inhibit the activity of intratumoral T-cells. The present study evaluated whether GM-CSF production and the presence of CD34+ cells within primary HNSCC would translate into increased recurrence, metastasis or cancer-related death during the 2 years following surgical excision. Freshly excised primary HNSCC of 20 patients that subsequently developed disease, and of 17 patients that remained with no evidence of disease were analyzed for production of GM-CSF and for CD34+ cell content. The cancers of patients that subsequently developed recurrences or metastatic disease produced almost 4-fold the levels of GM-CSF and had approximately 2.5-fold the number of CD34+ cells as did cancers of patients that remained disease-free. In a second method of analysis, the prognostic significance of high vs. low GM-CSF and CD34+ cell values was evaluated. These analyses showed that patients whose cancers produced high GM-CSF levels or had a high CD34+ cell content had a disproportionately high incidence of recurrence or metastatic disease (94% and 100%, respectively), while the majority of patients whose primary cancers produced low levels of GM-CSF or had a low CD34+ cell content remained disease-free (16% and 19%, respectively). Our results indicate that the presence of CD34+ cells in GM-CSF-producing HNSCC is associated with a poorer prognosis for the cancer patients and suggest the utility of these parameters as prognostic indicators of outcome. Mechanistically, our results suggest that the presence of immune suppressive CD34+ cells in GM-CSF-producing HNSCC leads to increased tumor recurrence or metastasis.
Subject(s)
Antigens, CD34/analysis , Antigens, CD/analysis , Biomarkers, Tumor/analysis , Carcinoma, Squamous Cell/pathology , Granulocyte-Macrophage Colony-Stimulating Factor/biosynthesis , Head and Neck Neoplasms/pathology , T-Lymphocytes, Regulatory/pathology , Adult , Aged , Carcinoma, Squamous Cell/immunology , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/physiopathology , Female , Follow-Up Studies , Granulocyte-Macrophage Colony-Stimulating Factor/analysis , Head and Neck Neoplasms/immunology , Head and Neck Neoplasms/mortality , Head and Neck Neoplasms/physiopathology , Humans , Male , Middle Aged , Neoplasm Metastasis , Neoplasm Staging , Prognosis , Recurrence , Survival Rate , T-Lymphocytes, Regulatory/immunology , Time FactorsABSTRACT
The role of protein phosphatase-2A (PP-2A) in regulating the motility and adhesion of human head and neck squamous cell carcinomas (HNSCC) was investigated. Immunofluorescent staining of these HNSCC cells showed PP-2A can co-localize with microtubules. That the PP-2A influences motility was shown by the increase in HNSCC cell migration through laminin and vitronectin when PP-2A was selectively inhibited with low dose okadaic acid, and by the reduction in invasion through these same matrix components by elevators of PP-2A activity. Motility of HNSCC cells through collagen I or fibronectin was not modulated by PP-2A. The reduction in HNSCC migration through vitronectin or laminin that resulted from treatment with PP-2A elevators was associated with an increase in cellular adhesiveness to these same ECM components. These studies show the association of PP-2A with the cellular cytoskeleton and its role in restricting the invasiveness of tumor cells through select extracellular matrix components.
Subject(s)
Carcinoma, Squamous Cell/metabolism , Head and Neck Neoplasms/metabolism , Head and Neck Neoplasms/pathology , Microtubules/metabolism , Neoplasm Proteins/metabolism , Phosphoprotein Phosphatases/metabolism , Calcitriol/pharmacology , Carcinoma, Squamous Cell/secondary , Ceramides/pharmacology , Humans , Neoplasm Invasiveness , Neoplasm Proteins/antagonists & inhibitors , Okadaic Acid/pharmacology , Phosphoprotein Phosphatases/antagonists & inhibitors , Protein Phosphatase 2 , Tumor Cells, Cultured/drug effectsABSTRACT
Cancers, such as human head and neck squamous cell carcinomas (HNSCC), have been shown to stimulate angiogenesis by their production of endothelial cell proliferative and motility-stimulatory factors. The present studies to elucidate the intracellular mechanisms that contribute to the motility response of endothelial cells to HNSCC-derived factors showed a decline in the organization of actin filaments and microtubules. This HNSCC-induced decline in cytoskeletal organization coincided with the downregulation of endothelial cell protein phosphatase-1 and 2A (PP-1/2A) activities, and could be mimicked by directly inhibiting these enzyme activities with okadaic acid. These results show that the increased motility of endothelial cells in response to HNSCC-derived angiogenic factors involves downregulation of PP-1/2A activities and, consequently, a decline in cytoskeletal organization.
Subject(s)
Actins/metabolism , Carcinoma, Squamous Cell/pathology , Cytoskeleton/physiology , Endothelium, Vascular/physiology , Head and Neck Neoplasms/pathology , Phosphoprotein Phosphatases/physiology , Cell Movement , Down-Regulation , Endothelium, Vascular/cytology , Humans , Phosphoprotein Phosphatases/antagonists & inhibitors , Protein Phosphatase 1 , Tumor Cells, CulturedABSTRACT
Freshly excised human head and neck cancers (219 primary cancers; 64 metastatic lymph node cancers) were analyzed for the immune inhibitory mediators released from the cancer tissues and the immune infiltrate within the tumor. Significant levels of the immune inhibitory mediators transforming growth factor-beta (TGF-beta), prostaglandin E2 (PGE2) and interleukin-10 (IL-10) were released from these cancers. Also released was granulocyte-macrophage colony-stimulating factor (GM-CSF), whose secretion was associated with an intratumoral presence of CD34+ cells. We have previously shown that CD34+ cells within human head and neck cancers are immune inhibitory granulocyte-macrophage progenitor cells. The presence of TGF-beta, PGE2 and IL-10 was associated with a reduced content of CD8+ T-cells within the cancers. The CD4+ cell content appeared to be less affected by these immune inhibitory mediators. Instead, parameters indicative of CD4+ cell function (p55 IL-2 receptor expression, release of IL-2 and IFN-gamma) were diminished in cancers that released higher levels of TGF-beta, IL-10 and GM-CSF and had a higher CD34+ cell content. Furthermore, metastatic cancers released higher levels of the soluble immune inhibitory mediators and lower levels of IFN-gamma and IL-2 than did primary cancers, although CD34+ cells were similarly present in both primary and metastatic cancers. Our results show that human head and neck cancers have a multiplicity of non-mutually exclusive mechanisms of immune suppression that are most prominently associated with reduced CD8+ cell influx and reduced influx and altered function of intratumoral CD4+ cells.
Subject(s)
Head and Neck Neoplasms/immunology , Immune Tolerance/immunology , Lymphocytes, Tumor-Infiltrating/immunology , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Dinoprostone/metabolism , Granulocyte-Macrophage Colony-Stimulating Factor/metabolism , Head and Neck Neoplasms/metabolism , Humans , Interferon-gamma/metabolism , Interleukin-10/metabolism , Interleukin-2/metabolism , Lymphatic Metastasis , Transforming Growth Factor beta/metabolismABSTRACT
Human head and neck squamous cell carcinoma (HNSCC) cell cultures were established to identify the angiogenic factors they produced and how these factors contribute to two steps of the angiogenic process: endothelial cell proliferation and migration. The HNSCC cells secreted vascular endothelial cell growth factor (VEGF), transforming growth factor-beta (TGF-beta) and prostaglandin E2 (PGE2), but only low levels of basic fibroblast growth factor. Both proliferation-stimulatory and -inhibitory cytokines were produced by the HNSCC cells, with VEGF promoting endothelial cell proliferation, prostaglandins having no effect and TGF-beta downregulating proliferation. Two methods were used to measure endothelial cell migration: migration into a wound in the endothelial cell monolayer and migration across a filter into lower compartments. HNSCC cell supernatants stimulated endothelial cell migration in both migration models. VEGF had no effect on the motility of endothelial cells. However, when TGF-beta activity in the HNSCC supernatants was neutralized with antibody or the production of prostaglandins by HNSCC cells was blocked with indomethacin, the migration-stimulatory activity in the HNSCC cell supernatants was diminished. Adding authentic PGE2 or TGF-beta 1 to endothelial cells mimicked the migration-stimulatory activity of the HNSCC supernatants. Thus, HNSCC-derived VEGF is important in stimulating endothelial cell proliferation, while the antiproliferative effect of TGF-beta and the migration-stimulatory activity of TGF-beta and PGE2 suggest their having a role in the morphogenic processes of angiogenesis.